Article Details
Retrieved on: 2024-08-17 22:01:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA approved the interleukin (IL)-31 monoclonal antibody nemolizumab (Nemluvio) for which dermatologic condition? Alopecia areata. Molluscum ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here